CNBX Pharmaceuticals CNBX
OTC CNBX
$0.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

CNBX Pharmaceuticals Inc. (CNBX) Interest Coverage Ratio (2013 - 2026)

CNBX Pharmaceuticals' (CNBX) quarterly Interest Coverage Ratio came in at 2.24 in Q1 2026, up 114.48% YoY from 1.04 in Q1 2025, and up 261.79% on a QoQ basis from 1.38 in Q4 2025.

CNBX Pharmaceuticals Inc. (CNBX) Interest Coverage Ratio (2013 - 2026) Analysis & Trends

CNBX Pharmaceuticals (CNBX) has 14 years of Interest Coverage Ratio data on file, last reported at 2.24 in Q1 2026.

  • Quarterly Interest Coverage Ratio rose 114.48% year-over-year to 2.24 in Q1 2026, while the trailing twelve-month figure through May 2026 was 15.43 (down 120.52% YoY) and the FY2025 annual result came in at 0.08, up 54.34% from the prior year.
  • Interest Coverage Ratio rose to 2.24 in Q1 2026, from 1.38 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 19.16 in Q2 2023 to a low of 137.56 in Q3 2023.
  • A 5-year average of 24.4 and a median of 12.71 in 2022 frame the typical range for Interest Coverage Ratio.
  • The widest YoY moves for Interest Coverage Ratio: up 240.74% in 2023, down 3775.5% in 2023.
  • Tracing CNBX's Interest Coverage Ratio over 5 years: stood at 76.37 in 2022, then surged by 80.34% to 15.01 in 2023, then increased by 21.4% to 11.8 in 2024, then soared by 88.28% to 1.38 in 2025, then soared by 261.79% to 2.24 in 2026.
  • The last three Interest Coverage Ratio figures came in at 2.24 (Q1 2026), 1.38 (Q4 2025), and 0.04 (Q3 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Feb 28, 2026 2.24
Nov 30, 2025 -1.38
Aug 31, 2025 -0.04
May 31, 2025 -2.85
Feb 28, 2025 -15.45
Nov 30, 2024 -11.80
Aug 31, 2024 -8.30
Feb 29, 2024 -38.61
Nov 30, 2023 -15.01
Aug 31, 2023 -137.56
May 31, 2023 19.16
Feb 28, 2023 -55.64
Nov 30, 2022 -76.37
Aug 31, 2022 -33.80
May 31, 2022 -13.61
Feb 28, 2022 -1.44
Aug 31, 2021 -7.03
May 31, 2021 -1.04
Feb 28, 2021 -10.63
Aug 31, 2020 -0.19